MESOSMALL

Mesoblast Limited

HealthcareBiotechnology
$13.61
$0.00(+3.18%)
52W$10.32
$21.50
Updated Jun 30, 02:00 AM
RSI38
RS Rating21/99
Beta1.55
Volatility64%
F-Score5/9
Mkt Cap$1.8B
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

Mesoblast Limited is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 21), showing significant lag compared to the market leaders. Earnings growth of 16% provides fundamental context to the price action. Investors should exercise caution due to high volatility (64% annualized), which requires wider risk management.

Relative Strength
21
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
1.55
vs S&P 500
HIGH BETA
52W Position
29%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$14.89
50 SMA > 100 SMA$15.22
100 SMA > 150 SMA$16.16
150 SMA > 200 SMA$16.24

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$14.31-4.92%BELOW
50 SMA$14.89-8.57%BELOW
100 SMA$15.22-10.57%BELOW
150 SMA$16.16-15.76%BELOW
200 SMA$16.24-16.19%BELOW

Price Performance

1D+3.2%
1W-12.2%
1M-11.6%
3M-5.3%
6M-28.2%
YTD-25.1%
1Y+25.0%
3Y+20.4%
52-Week Trading Range29% from low
$13.61
52W Low$10.32
52W High$21.50

Technical Indicators

RSI (14)BEARISH
38.5
305070
Setup ScoreCOOL
2/10
Base depth: 28.2%

Risk Profile

Beta
1.55
52W Vol
64%
ATR
$0.66
Max DD (1Y)
-37%

Volume Analysis

Today
150.6K
50D Avg
151.3K
Vol Ratio
1.00x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25-11%
$-0.21
Q2'25-11%
$-0.21
Q3'25+16%
$-0.21
Q4'25+16%
$-0.21
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-3.18%
5 Years:-11.76%
3 Years:+18.98%
TTM:+191.39%

Compounded Profit Growth

10 Years:+9.18%
5 Years:
3 Years:
TTM:+4.55%

Stock Price CAGR

10 Years:+5.51%
5 Years:-2.47%
3 Years:+20.39%
1 Year:+24.98%

Return on Equity

10Y Avg:-14.2%
5Y Avg:-17.5%
3Y Avg:-17.8%
Last Year:-17.1%

Key Metrics

Market Cap$1.8B
Gross Margin70.2%
Net Margin-5.9%
Piotroski F-Score5/9

Frequently Asked Questions

Is MESO in an uptrend right now?

MESO has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is MESO overbought or oversold?

MESO's RSI (14) is 38. The stock is in neutral territory, neither overbought nor oversold.

Is MESO outperforming the market?

MESO has a Relative Strength (RS) Rating of 21 out of 99. MESO is currently lagging the broader market.

Where is MESO in its 52-week range?

MESO is trading at $13.61, which is 63% of its 52-week high ($21.50) and 29% above its 52-week low ($10.32).

How volatile is MESO?

MESO has a Beta of 1.55 and 52-week volatility of 64%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.